Published in Neurosci Lett on June 19, 1998
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A (2000) 3.86
Prion-like spreading of pathological α-synuclein in brain. Brain (2013) 2.92
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J Neurosci (2009) 2.82
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A (1999) 2.30
Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A (2013) 2.19
100 years of Lewy pathology. Nat Rev Neurol (2012) 2.15
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A (2015) 2.08
The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol (2010) 1.80
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci (2009) 1.66
Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol (1999) 1.65
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener (2012) 1.63
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol (2000) 1.50
The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding. Biophys J (2010) 1.39
Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol (2005) 1.36
Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Philos Trans R Soc Lond B Biol Sci (1999) 1.21
Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci (2010) 1.20
Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm (Vienna) (2005) 1.20
Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci (2011) 1.18
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. Brain (2012) 1.15
Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Am J Pathol (1999) 1.14
The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol Commun (2013) 1.11
Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS One (2013) 1.10
p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol (2007) 1.08
TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol Dis (2010) 1.08
Late-onset neurodegenerative diseases--the role of protein insolubility. J Anat (2000) 1.07
Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies. Pharmacol Ther (2013) 1.06
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol (2011) 1.06
Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J Biol Chem (2009) 1.05
Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci U S A (2015) 1.04
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain (2014) 1.03
Survival in synucleinopathies: A prospective cohort study. Neurology (2015) 1.02
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy. Exp Neurol (2012) 1.01
Recent developments in multiple system atrophy. J Neurol (2009) 1.00
Role of synucleins in Alzheimer's disease. Neurotox Res (2009) 0.98
Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease. Parkinsons Dis (2011) 0.95
Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. J Clin Invest (2011) 0.93
An update on the cerebellar subtype of multiple system atrophy. Cerebellum Ataxias (2014) 0.91
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J Parkinsons Dis (2013) 0.91
Melittin restores proteasome function in an animal model of ALS. J Neuroinflammation (2011) 0.91
Antibodies against alpha-synuclein reduce oligomerization in living cells. PLoS One (2011) 0.91
Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol Commun (2015) 0.90
Defined α-synuclein prion-like molecular assemblies spreading in cell culture. BMC Neurosci (2014) 0.90
Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol (2004) 0.88
Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int (2013) 0.87
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia (2013) 0.87
Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway. Cell Mol Neurobiol (2007) 0.87
Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol (2015) 0.86
Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models. Biomolecules (2015) 0.86
FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy. PLoS One (2013) 0.84
Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging (2011) 0.84
The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation. J Biol Chem (2016) 0.84
α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies. Int J Alzheimers Dis (2012) 0.83
Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy. Acta Histochem Cytochem (2010) 0.82
Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations. Clin Exp Immunol (2010) 0.82
Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy. Parkinsons Dis (2015) 0.82
α-Synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis. J Neural Transm (Vienna) (2011) 0.81
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. Parkinsonism Relat Disord (2015) 0.81
Defining the oligomerization state of γ-synuclein in solution and in cells. Biochemistry (2014) 0.81
Modelling progressive autonomic failure in MSA: where are we now? J Neural Transm (Vienna) (2011) 0.81
Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity. Neurobiol Dis (2015) 0.80
Multiple system atrophy: genetic or epigenetic? Exp Neurobiol (2014) 0.80
Molecular chaperones in Parkinson's disease--present and future. J Parkinsons Dis (2011) 0.80
α-Synuclein: Multiple System Atrophy Prions. Cold Spring Harb Perspect Med (2017) 0.80
Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Neurobiol Dis (2015) 0.79
Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies? J Neurol (2009) 0.79
SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res (2013) 0.79
Gaucher disease and the synucleinopathies: refining the relationship. Orphanet J Rare Dis (2012) 0.79
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism Relat Disord (2015) 0.79
A genome-wide association study in multiple system atrophy. Neurology (2016) 0.78
Therapeutic approaches in Parkinson's disease and related disorders. J Neurochem (2016) 0.78
Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy. Acta Neuropathol Commun (2015) 0.78
Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation. J Virol (2016) 0.78
α-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease. Ann Clin Transl Neurol (2016) 0.77
Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications. PLoS One (2016) 0.77
Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures. Comput Math Methods Med (2013) 0.77
The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type. Cerebellum (2016) 0.77
Sympathetic neuroimaging. Handb Clin Neurol (2013) 0.77
Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy. Neuropathol Appl Neurobiol (2016) 0.76
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders? Mol Neurobiol (2015) 0.76
Novel therapeutic approaches in multiple system atrophy. Clin Auton Res (2014) 0.76
Comparison of alpha-synuclein immunoreactivity in the spinal cord between the adult and aged beagle dog. Lab Anim Res (2012) 0.75
Loss of DARPP-32 and calbindin in multiple system atrophy. J Neural Transm (Vienna) (2013) 0.75
Parkinsonism and tremor disorders. A clinical approach. Libyan J Med (2007) 0.75
Relocation of p25α/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy. Acta Neuropathol Commun (2014) 0.75
The Synucleinopathies: Twenty Years On. J Parkinsons Dis (2017) 0.75
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies. Parkinsonism Relat Disord (2016) 0.75
Multiple system atrophy: clinicopathological characteristics in Japanese patients. Proc Jpn Acad Ser B Phys Biol Sci (2017) 0.75
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles. PLoS One (2017) 0.75
Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism. F1000Res (2017) 0.75
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature (1984) 8.02
Existence of distinct sodium channel messenger RNAs in rat brain. Nature (1986) 7.87
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell (1998) 7.25
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature (1987) 6.66
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (1986) 4.97
Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol (2001) 4.96
Heterogeneity of the principal sigma factor in Escherichia coli: the rpoS gene product, sigma 38, is a second principal sigma factor of RNA polymerase in stationary-phase Escherichia coli. Proc Natl Acad Sci U S A (1993) 4.92
The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron (1995) 4.78
Structural homology of Torpedo californica acetylcholine receptor subunits. Nature (1983) 4.70
Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J (2009) 4.63
Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science (2001) 4.13
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1993) 3.73
Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature (1982) 3.69
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet (1994) 3.39
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology (2010) 3.34
Primary structure of the alpha-subunit of transducin and its relationship to ras proteins. Nature (1985) 3.28
Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature (1982) 3.09
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07
Modified formalin test: characteristic biphasic pain response. Pain (1989) 3.00
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int (2006) 3.00
Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology (2008) 2.85
Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature (1982) 2.79
A consensus linkage map of the chicken genome. Genome Res (2000) 2.79
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet (2001) 2.79
Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature (1983) 2.78
A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med (1987) 2.77
Atomic Control of the SrTiO3 Crystal Surface. Science (1994) 2.72
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med (1995) 2.63
Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res (2000) 2.61
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res (1994) 2.61
Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science (1991) 2.56
Primary structures of beta- and delta-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences. Nature (1983) 2.55
Cloning and nucleotide sequence of phoP, the regulatory gene for alkaline phosphatase and phosphodiesterase in Bacillus subtilis. J Bacteriol (1987) 2.52
Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51
A spin-valve-like magnetoresistance of an antiferromagnet-based tunnel junction. Nat Mater (2011) 2.47
Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40
Location of functional regions of acetylcholine receptor alpha-subunit by site-directed mutagenesis. Nature (1985) 2.40
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A (2001) 2.39
Primary structure of rat brain sodium channel III deduced from the cDNA sequence. FEBS Lett (1988) 2.39
Structure of the 5' upstream region and the regulation of the rpoS gene of Escherichia coli. Mol Gen Genet (1994) 2.38
SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet (2001) 2.30
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat (2011) 2.30
Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol (1989) 2.28
Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). Neurology (1990) 2.21
Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology (1994) 2.20
Inorganic polyphosphate and the induction of rpoS expression. Proc Natl Acad Sci U S A (1997) 2.19
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol (1991) 2.17
Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol (1995) 2.10
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest (1999) 2.09
An autopsy case of troglitazone-induced fulminant hepatitis. Diabetes Care (1998) 2.08
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut (2008) 2.05
Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett (1986) 2.03
Nucleotide sequence of the Bacillus subtilis phoR gene. J Bacteriol (1988) 2.02
Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor. Proc Natl Acad Sci U S A (1987) 2.02
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol (1988) 2.01
NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett (1997) 2.01
Total deletion and a missense mutation of ITPR1 in Japanese SCA15 families. Neurology (2008) 2.00
Abortive bacteriophage T4 head assembly in mutants of Escherichia coli. J Mol Biol (1973) 2.00
Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology (1993) 1.96
Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology (1991) 1.94
Neuromyelitis optica preceded by hyperCKemia episode. Neurology (2010) 1.94
Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc Natl Acad Sci U S A (2001) 1.93
Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax (1999) 1.93
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
Detection and recovery of mycobacteria by a radiometric procedure. J Clin Microbiol (1983) 1.92
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet (1998) 1.91
Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009. Euro Surveill (2009) 1.91
Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer (1995) 1.91
The effect of spo0 mutations on the expression of spo0A- and spo0F-lacZ fusions. Mol Gen Genet (1986) 1.89
Treatment of gallbladder cancer by radical resection. Br J Surg (1999) 1.88
Nuclear magnetic resonance study of antibodies: a multinuclear approach. Methods Enzymol (1994) 1.85
Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney Int (2007) 1.83
Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol (1999) 1.83
Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology (2004) 1.82
Multiple principal sigma factor homologs in eubacteria: identification of the "rpoD box". Science (1988) 1.81
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol (2001) 1.81
Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med (1985) 1.81
DNA mutation analysis of Gaucher patients. Am J Med Genet (1992) 1.80
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis (2007) 1.79
Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol (1990) 1.78
A single stage posterior approach and rigid fixation for preventing kyphosis in the treatment of spinal tuberculosis. Spine (Phila Pa 1976) (1994) 1.77
Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol (1990) 1.76
Detection of 16 gamma-ray pulsars through blind frequency searches using the Fermi LAT. Science (2009) 1.74
Differential regulation of spo0A transcription in Bacillus subtilis: glucose represses promoter switching at the initiation of sporulation. J Bacteriol (1991) 1.73
Inducer exclusion in Escherichia coli by non-PTS substrates: the role of the PEP to pyruvate ratio in determining the phosphorylation state of enzyme IIAGlc. Mol Microbiol (1998) 1.73